Management of iron overload in myelodysplastic syndromes: combined deferasirox and deferoxamine in a patient with liver disease

Blood Transfus. 2018 Jan;16(1):32-35. doi: 10.2450/2016.0137-16. Epub 2016 Oct 24.

Authors

Claudio Cerchione¹, Giuseppe Cerciello¹, Simona Avilia¹, Roberta Della Pepa¹, Novella Pugliese¹, Marco Picardi¹, Lucio Catalano¹, Fabrizio Pane¹

Affiliation

¹ Haematology Division, "Federico II" University Hospital, Naples, Italy.

No abstract available

Publication types

Case Reports

MeSH terms

Deferasirox / administration & dosage*
Deferoxamine / administration & dosage*
Hepatitis C / blood
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Hypertension, Portal / blood
Hypertension, Portal / complications
Hypertension, Portal / drug therapy*
Iron Overload / blood
Iron Overload / complications
Iron Overload / drug therapy*
Liver Cirrhosis / blood
Liver Cirrhosis / complications
Liver Cirrhosis / drug therapy*
Male
Middle Aged
Myelodysplastic Syndromes / blood
Myelodysplastic Syndromes / complications
Myelodysplastic Syndromes / drug therapy*

Substances

Deferoxamine
Deferasirox